ACRO BIOMEDICAL CO., LTD. Quarterly Debt-to-equity in % from Q4 2016 to Q4 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Acro Biomedical Co., Ltd. quarterly Debt-to-equity history and growth rate from Q4 2016 to Q4 2022.
  • Acro Biomedical Co., Ltd. Debt-to-equity for the quarter ending December 31, 2022 was 24.2 %, a 9.49% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 24.2 +2.1 +9.49% Dec 31, 2022
Q3 2022 19.1 -10.4 -35.3% Sep 30, 2022
Q2 2022 14.8 -19.5 -56.9% Jun 30, 2022
Q1 2022 13 -23.4 -64.3% Mar 31, 2022
Q4 2021 22.1 -5.89 -21% Dec 31, 2021
Q3 2021 29.5 +7.93 +36.8% Sep 30, 2021
Q2 2021 34.3 +15 +77.6% Jun 30, 2021
Q1 2021 36.4 +19.2 +111% Mar 31, 2021
Q4 2020 28 +11.3 +67.9% Dec 31, 2020
Q3 2020 21.6 +7.18 +50% Sep 30, 2020
Q2 2020 19.3 +5.12 +36.1% Jun 30, 2020
Q1 2020 17.2 +0.06 +0.35% Mar 31, 2020
Q4 2019 16.7 -3.66 -18% Dec 31, 2019
Q3 2019 14.4 -11.7 -44.9% Sep 30, 2019
Q2 2019 14.2 -11.4 -44.5% Jun 30, 2019
Q1 2019 17.2 -8.63 -33.5% Mar 31, 2019
Q4 2018 20.4 -4.1 -16.8% Dec 31, 2018
Q3 2018 26.1 +1.23 +4.95% Sep 30, 2018
Q2 2018 25.6 +137 Jun 30, 2018
Q1 2018 25.8 +141 Mar 31, 2018
Q4 2017 24.5 +176 Dec 31, 2017
Q3 2017 24.9 Sep 30, 2017
Q2 2017 -112 Jun 30, 2017
Q1 2017 -115 Mar 31, 2017
Q4 2016 -151 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.